Document Detail


Implanted automatic defibrillators: effects of drugs and pacemakers.
MedLine Citation:
PMID:  2463613     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The automatic implantable cardioverter defibrillator is an effective device for prevention of sudden cardiac death. Patients who require the implantation of the device often require permanent pacing for symptomatic bradyarrhythmias and may require antiarrhythmic drug therapy. Antiarrhythmic drugs may alter the defibrillation thresholds, arrhythmia cycle length and frequency, pacing thresholds and postshock excitability. Interactions between the defibrillator and the pacemaker may result in sensing problems, leading to multiple counting and inappropriate shocks, or ventricular fibrillation nondetection, sensing or capture failure post defibrillation and pacemaker reprogramming induced by defibrillator discharge. The potential for interactions will increase as the new generation of programmable defibrillators become clinically available, combining features of permanent pacemakers, antitachycardia pacemakers and defibrillators.
Authors:
I Singer; T Guarnieri; J Kupersmith
Related Documents :
8461513 - Does ventricular fibrillation cause myocardial stunning during defibrillator implantation?
16407703 - Implantable cardioverter-defibrillators: a new preventive medical option.
20111653 - A case of acute myocardial infarction caused by distal embolization of a left main coro...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Pacing and clinical electrophysiology : PACE     Volume:  11     ISSN:  0147-8389     ISO Abbreviation:  Pacing Clin Electrophysiol     Publication Date:  1988 Dec 
Date Detail:
Created Date:  1989-02-16     Completed Date:  1989-02-16     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  7803944     Medline TA:  Pacing Clin Electrophysiol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  2250-62     Citation Subset:  IM    
Affiliation:
Cardiovascular Division, University of Louisville, KY 40202.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anti-Arrhythmia Agents / therapeutic use*
Arrhythmias, Cardiac / prevention & control*
Combined Modality Therapy
Death, Sudden*
Electric Countershock / instrumentation*
Electrodes, Implanted
Humans
Pacemaker, Artificial*
Ventricular Fibrillation / prevention & control*
Chemical
Reg. No./Substance:
0/Anti-Arrhythmia Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A canine model of torsades de pointes.
Next Document:  Quality of life of oncology hospice patients: a comparison of patient and primary caregiver reports.